Research Articles

Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery.

Christiansen D, Earnest-Silveira L, Grubor-Bauk B, Wijesundara DK, Boo I, Ramsland PA, Vincan E, Drummer HE, Gowans EJ, Torresi J

The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study.

Weil GJ, Bogus J, Christian M, Dubray C, Djuardi Y, Fischer PU, Goss CW, Hardy M, Jambulingam P, King CL, Kuttiat VS, Krishnamoorthy K, Laman M, Lemoine JF, O'Brian KK, Robinson LJ, Samuela J, Schechtman KB, Sircar A, Srividya A, Steer AC, Supali T, Subramanian S, DOLF IDA Safety Study Group

Measures of harm reduction service provision for people who inject drugs.

O'Keefe D, Bluthenthal RN, Kral AH, Aitken CK, McCormack A, Dietze PM

How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy.

Jaworowski A, Hearps AC, Angelovich TA, Hoy JF

A qualitative investigation of barriers, support-seeking and coping among South Sudanese people with chronic hepatitis B in Australia.

William Mude, Christopher Fisher, Jacqui Richmond, Jack Wallace, Roslyn Le Gautier

Hepatitis B

Synergy in anti-malarial pre-erythrocytic and transmission-blocking antibodies is achieved by reducing parasite density.

Sherrard-Smith E, Sala KA, Betancourt M, Upton LM, Angrisano F, Morin MJ, Ghani AC, Churcher TS, Blagborough AM

Malaria